Now accepting presenters!

Advancements in the Comprehensive Treatment of Stuttering At the conclusion of the presentation, the participant shall be able to 1. Summarize the challenges in assessing the effects of stuttering over time. 2. Describe models of comprehensive treatment approaches to assist persons who stutter Gerald A Maguire, MD is a person who stutters and is dedicating his life's work to improving the lives of those who stutter through advocacy, education, research and clinical care. Dr. Maguire has published over seventy scientific papers and numerous books/chapters and has delivered hundreds of invitated presentations throughout the world. He serves as the Chair of Research and Development for the World Stuttering Network, Medical Director of iStutter, Professor Emeritus at the University of California, Riverside School of Medicine, Professor, American University of Health Sciences, Director of Residency Training in Psychiatry at College Medical Center and Principal Investigator at Cenexel--CIT research. He has served as Chair of the National Stuttering Association and Vice Chair of the International Stuttering Association. Financial disclosures: Dr. Maguire received research grants from Noema, Emalex, Intracellular. Non-financial disclosures: He serves as an advisor for Noema

Game Changer: The Role of Artificial Intelligence in Stuttering Therapy By the end of this presentation, 1. Participants will list the fundamental principles of how artificial intelligence can be integrated into stuttering therapy. 2. Attendees will describe insights into the current research, potential applications, and future directions of AI in the assessment and treatment of stuttering, as well as the ethical considerations and the importance of human oversight in technology-assisted therapies. Goncalo Leal is a Speech and Language Therapist, Co-Founder and Clinical Director at Speechcare / iStutter Center (Portugal, Spain, UAE). He is a guest Professor and mentor in “Specialization on Fluency Disorders“ at Faculty of Medicine of Concepción’s University, Chile. Founding member of the Portuguese Society of Speech Therapy. Clinical Educator in stuttering with academic collaborations and courses held in over 20 countries in Europe, Latin America, Africa, and the Middle East. He is co-author of books, chapters, and papers in stuttering. He plays the role of advisor in technology companies in projects related to fluency disorders. Financial disclosures: Mr. Leal receives payments for educatioal services from University of Concepcion in Chile. Non-financial disclosures: He conducts research on artificial intelligence with MBZUAI.

Is it Possible to Prevent Stuttering? At the end of this presentation, participants will be able to: 1. Discuss the types of prevention defined by the World Health Organization. 2. Describe the need to care for the future of children who stutter. Anelise Junqueira Bohnen, PhD is a speech and fluency clinician with the Regional Council of Speech, Language and Audiology - CRFa 5587 / RS. She is a fluency specialist with the Brazilian Federal Council of Speech, Language and Audiology. She has a PhD in Applied Linguistics from the Federal University of Rio Grande do Sul and a Master in Speech and Language Pathology from Ithaca College, USA. Dr. Bohnen is the president of the Brazilian Fluency Institute (IBF) and International Coordinator of Diplomado en Trastornos de la Fluidez del Habla – Universidad de Concepción, Chile. She is also a member of the Scientific Advisory Board for the Tartamudez Center in Portugal and the Scientific Advisory Board at Parlo Institut, Germany. Dr. Bohnen is the author of books, chapters and papers in the fluency disorders field. She presents about fluency disorders nationally and internationally. Financial Disclosures: Dr. Bohnen is a private SLP who works with fluency disorders. Non-Financial Disclosures: Dr. Bohnen serves both on a scientific committee and as a peer reviewer. Her work as president of IBF is pro-bono.

Social anxiety disorder and stuttering At the end of this presentation, participants will be able to describe how social anxiety disorder is related with repetitive negative thinking. Dr. Kikuchi is an assistant professor at the Medical School of Kyushu University in Japan, holds a PhD in Medicine, and is a physician with a stutter. He has consulted with more than 600 individuals who stutter and has written 15 books on stuttering in Japanese. In 2023, he spent four months in Southern California conducting joint research with Dr. Maguire. Dr. Kikuchi has no relevant financial or non-financial disclosures.

Stuttering: Clinical Care, Research and Advocacy By the end of this presentation, participants will be able to: 1. To discuss the distinct roles of clinical intervention, research and advocacy related to stuttering. 2. To discuss the integration of clinical care, research and advocacy related to stuttering. Joseph Donaher, Ph.D., is the Academic and Research Program Director of the Center for Childhood Communication at the Children's Hospital of Philadelphia. Dr. Donaher is an Adjunct Associate Professor of Otorhinolaryngology at The University of Pennsylvania. He is a Board Certified Specialist in Stuttering, Cluttering and Fluency. His clinical and research interests focus on the assessment and treatment of school-age children who stutter and disfluency patterns secondary to neurological conditions. Financial disclosures: Dr. Donaher receives a salary from CHOP. Non-financial disoclosures: Dr. Donaher serves on the Board of Advisors for Change and Impact, Inc., an organization founded by NBA player Michael Kidd-Gilchrist to improve access to healthcare and expand services and resources for those who stutter. He is also on the board of the Nolan Stuttering Foundation which produces the Stuttering Springboard Podcast.

What Animal Models Can Tell Us About Stuttering At the end of this presenatation, participants will be able to describe and discuss what animal models tell us about stuttering. Dr. Shahriar SheikhBahaei received his PhD from the University College London (UCL)-National Institutes of Health (NIH) joint doctoral program in neuroscience. His doctoral research evaluated role of astrocytes in modulation of respiratory motor circuits. Currently, he is a Principal Investigator at the Intramural Research Program (IRP) of the National Institute of Neurological Disorders and Stroke (NINDS), USA. As the head of the Neuron-Glia Signaling and Circuits Lab, he leads a research group that studies the development of motor circuits in mammals and investigates motor control disorders, including speech disorders. Financial disclosures: Dr. SheikhBahei us an employee of US Government and all the research is supported by the National Institutes of Health (NIH). Non-financial disclosures: None

Stuttering Treatment Outcome Measure Considerations As treatment approaches for stuttering have expanded, so too have treatment outcome possibilities. 1. Learners will restate how treatment has expanded and connect these treatment approaches to their related outcomes. 2. Learners will describe the various treatment outcomes in terms of means and standard deviations currently available so as so assess effect size and sample size possibilities. Dr. Lisa LaSalle is a professor and speech-language pathologist with over 30 years of experience working with people of all ages who stutter. She currently on the faculty of the Masters-SLP program at California State University-Monterey Bay, where she teaches supervises and researches. Dr. LaSalle's current interests include the dopamine hypothesis of developmental and acquired stuttering, preschool stuttering prevention, and children who stutter and present with co-occurring disorders (e.g., speech sound disorders). Financial disclosures: None Non-financial disclosures: Dr. LaSalle co-authored two articles with Dr. Maguire.